Should heart age calculators be used alongside absolute cardiovascular disease risk assessment
Carissa Bonner,Katy J.L. Bell,Katy J.L. Bell,Jesse Jansen,Paul Glasziou,Paul Glasziou,Les Irwig,Jenny Doust,Jenny Doust,Kirsten McCaffery +9 more
Reads0
Chats0
TLDR
Interactive heart age tools may be helpful as a communication tool to initiate lifestyle change to reduce risk factors, but absolute risk should be used instead of heart age to enable informed decision making about medication, to avoid unnecessary treatment of low risk people.Abstract:
National estimates of ‘heart age’ by government health organisations in the US, UK and China show most people have an older heart age than current age. While most heart age calculators are promoted as a communication tool for lifestyle change, they may also be used to justify medication when clinical guidelines advocate their use alongside absolute risk assessment. However, only those at high absolute risk of a heart attack or stroke are likely to benefit from medication, and it is not always clear how heart age relates to absolute risk. This article aims to: 1) explain how heart age calculation methods relate to absolute risk guidelines; 2) summarise research investigating whether heart age improves risk communication; and 3) discuss implications for the use of medication and shared decision making in clinical practice. There is a large and growing number of heart age models and online calculators, but the clinical meaning of an older heart age result is highly variable. An older heart age result may indicate low, moderate or high absolute risk of a heart attack or stroke in the next 5-10 years, and the same individual may receive a younger or older heart age result depending on which calculator is used. Heart age may help doctors convey the need to change lifestyle, but it cannot help patients make an informed choice about medication to reduce CVD risk. Interactive heart age tools may be helpful as a communication tool to initiate lifestyle change to reduce risk factors. However, absolute risk should be used instead of heart age to enable informed decision making about medication, to avoid unnecessary treatment of low risk people. Evidence-based decision aids that improve patient understanding of absolute risk should be considered as alternatives to heart age calculators for lifestyle and medication decisions.read more
Citations
More filters
Journal ArticleDOI
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective.
TL;DR: There is a need to sensitize developers, healthcare professionals, and legislators to the challenges and limitations of opaque algorithms in medical AI and to foster multidisciplinary collaboration moving forward to ensure that medical AI lives up to its promises.
Journal ArticleDOI
Current Best Practice for Presenting Probabilities in Patient Decision Aids: Fundamental Principles
Carissa Bonner,Lyndal Trevena,Wolfgang Gaissmaier,Paul K. J. Han,Yasmina Okan,Elissa M. Ozanne,Ellen Peters,Danielle R.M. Timmermans,Brian J. Zikmund-Fisher +8 more
TL;DR: In this paper, the authors present a review of patient decision aids for shared decision making in a way they can easily understand and compare with the patient's decision process, and present evidence to convey to the patient.
Journal ArticleDOI
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
David Marais,Zeljko Reiner,Matteo Pirro,Manfredi Rizzo,Alexandros Sachinidis,Dan Gaita,Mohsen Mazidi,Daniel Pella,G.B. John Mancini,Stephan von Haehling,Maciej Banach,Julio Acosta,Mutaz Alkhnifsawi,Fahad Alnouri,Fahma Amar,Atanas G. Atanasov,G. Bajraktari,Sonu Bhaskar,Ibadete Bytyçi,Bojko Bjelakovic,Eric Bruckert,Alberto Cafferata,Richard Ceska,Arrigo F G Cicero,Xavier Collet,Magdalena Daccord,Olivier S. Descamps,Dragan Djuric,Ronen Durst,Marat V. Ezhov,Zlatko Fras,Adrian V. Hernandez,Steven P. Jones,Jacek Jerzy Jozwiak,N. Kakauridze,A. Kallel,Niki Katsiki,Amit Khera,Karam Kostner,Raimondas Kubilius,Gustavs Latkovskis,A. David Marais,Seth S. Martin,Julio A. Martínez,Dimitri P. Mikhailidis,Erkin M. Mirrakhimov,André R. Miserez,Olena Mitchenko,N.P. Mitkovskaya,Patrick M. Moriarty,Seyed Mohammad Nabavi,Devaki Nair,Demosthenes B. Panagiotakos,György Paragh,Peter E. Penson,Zaneta Petrulioniene,Arman Postadzhiyan,Raman Puri,Ashraf Reda,Dina Radenkovic,Michael Robert Rakowski,Jemaa Riadh,Dimitri Richter,Massimiliano Ruscica,Amirhossein Sahebkar,Naveed Sattar,Maria-Corina Serban,Abdullah Shehab,Aleksandr B Shek,Cesare R. Sirtori,Claudia Stefanutti,Tomasz Tomasik,Peter P. Toth,Margus Viigimaa,Pedro Valdivielso,Dragos Vinereanu,Branislav Vohnout,Michal Vrablík,Nathan D. Wong,Hung-I Yeh,Ji Zhisheng,Andreas Zirlik +81 more
TL;DR: A step‐by‐step patient‐centred approach to the identification and management of SAMS with a particular focus on strategies to prevent and manage the nocebo/drucebo effect and to improve long‐term compliance with lipid‐lowering therapy is presented.
Journal ArticleDOI
The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale, implications, and implementation.
TL;DR: Compared with current guidelines, treatment based on predicted therapy-benefit would increase eligibility for therapy among young people with a moderate risk-factor burden and individuals with a high residual risk.
Journal ArticleDOI
Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.
Laila Staerk,Laila Staerk,Sarah R. Preis,Honghuang Lin,Juan P. Casas,Kathryn L. Lunetta,Lu-Chen Weng,Lu-Chen Weng,Christopher D. Anderson,Patrick T. Ellinor,Patrick T. Ellinor,Steven A. Lubitz,Steven A. Lubitz,Emelia J. Benjamin,Ludovic Trinquart +14 more
TL;DR: The RMST can be used to develop risk prediction models to express results in a time scale and may offer a complementary risk communication tool for AF in clinical practice.
References
More filters
Journal ArticleDOI
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Massimo Piepoli,Arno W. Hoes,Stefan Agewall,Christian Albus,Carlos Brotons,Alberico L. Catapano,Marie Therese Cooney,Ugo Corrà,Bernard Cosyns,Christi Deaton,Ian D. Graham,Michael Stephen Hall,FD Richard Hobbs,Maja Lisa Løchen,Herbert Löllgen,Pedro Marques-Vidal,Joep Perk,Eva Prescott,Josep Redon,Dimitrios J. Richter,Naveed Sattar,Y.M. Smulders,Monica Tiberi,H. Bart van der Worp,Ineke van Dis,W M Monique Verschuren +25 more
TL;DR: In this paper, a randomized clinical trial was conducted to evaluate the effect of preterax and Diamicron Modified Release Controlled Evaluation (MDE) on the risk of stroke.
Journal ArticleDOI
General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study
Ralph B. D'Agostino,Ramachandran S. Vasan,Michael J. Pencina,Philip A. Wolf,Mark R. Cobain,Joseph M. Massaro,William B. Kannel +6 more
TL;DR: A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure) and can be used to quantify risk and to guide preventive care.
Journal ArticleDOI
Decision aids for people facing health treatment or screening decisions
Dawn Stacey,Dawn Stacey,Krystina B. Lewis,Michael J. Barry,Carol Bennett,Karen Eden,Margaret Holmes-Rovner,Hilary A. Llewellyn-Thomas,Anne Lyddiatt,Richard Thomson,Lyndal Trevena +10 more
TL;DR: Decision aids reduced the proportion of undecided participants and appeared to have a positive effect on patient-clinician communication, and those exposed to a decision aid were either equally or more satisfied with their decision, the decision-making process, and the preparation for decision making compared to usual care.
Journal ArticleDOI
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli,Arno W. Hoes,Stefan Agewall,Christian Albus,Carlos Brotons,Alberico L. Catapano,Marie Therese Cooney,Ugo Corrà,Bernard Cosyns,Christi Deaton,Ian D. Graham,Michael Stephen Hall,FD Richard Hobbs,Maja-Lisa Løchen,Herbert Löllgen,Pedro Marques-Vidal,Joep Perk,Eva Prescott,Josep Redon,Dimitrios J. Richter,Naveed Sattar,Yvo M. Smulders,Monica Tiberi,H. Bart van der Worp,Ineke van Dis,W. M. Monique Verschuren +25 more
TL;DR: ABI is ankle-brachial (blood pressure) index and ABPM is ambulatory blood pressure monitoring as mentioned in this paper ; ACCORD is action to control cardiovascular risk in Diabetes and Vascular disease.
Journal ArticleDOI
European guidelines on cardiovascular disease prevention.
TL;DR: These guidelines provide risk charts, Systematic Coronary Risk Evaluation (SCORE), predicting the 10-year risk of fatal cardiovascular disease including stroke deaths in the 40–65-year age group at given levels of blood pressure and cholesterol in women and men, smokers and nonsmokers.